Consolidated Balance Sheets - USD ($)
|
Dec. 31, 2019 |
Dec. 31, 2018 |
| Current Assets |
|
|
| Cash and cash equivalents |
$ 893,138
|
$ 950,237
|
| Accounts receivable, net |
131,382
|
13,420
|
| Inventory |
197,168
|
18,153
|
| Prepaid expenses |
362,566
|
70,103
|
| Total current assets |
1,584,254
|
1,051,913
|
| Property and equipment, net |
196,832
|
156,138
|
| Investment in joint venture |
434,240
|
345,121
|
| Total other long-term assets |
631,072
|
501,259
|
| Total assets |
2,215,326
|
1,553,172
|
| Current Liabilities |
|
|
| Accounts payable |
5,959
|
148,967
|
| Accrued expenses |
200,788
|
174,444
|
| Accrued expenses (related party) |
120,000
|
120,000
|
| Current notes payable net of $0 and $91,427 discount, respectively |
|
1,908,572
|
| Deferred income current |
1,323
|
|
| Total current liabilities |
328,070
|
2,351,983
|
| Long-term Liabilities |
|
|
| Accrued liabilities (related-party) |
150,000
|
260,000
|
| Total long-term liabilities |
150,000
|
260,000
|
| Total liabilities |
478,070
|
2,611,983
|
| Commitments and contingencies |
|
|
| STOCKHOLDERS' EQUITY (DEFICIT): |
|
|
| Preferred stock, $.001 par value, 5,000,000 shares authorized; 25,600 and no shares issued and outstanding, respectively |
26
|
|
| Common stock, $.001 100,000,000 shares authorized; 17,342,922 and 12,923,383 shares issued and outstanding, respectively |
17,343
|
12,923
|
| Additional paid-in capital |
26,687,701
|
17,622,433
|
| Accumulated deficit |
(24,967,814)
|
(18,694,167)
|
| Total stockholders' equity (deficit) |
1,737,256
|
(1,058,811)
|
| Total liabilities and stockholders' equity (deficit) |
$ 2,215,326
|
$ 1,553,172
|